MC
Martlet Capital
Venture CapitalActiveMartlet Capital is an early-stage investor, providing patient capital to deep tech and life science start-ups with high growth potential.
36
Investments
2
Exits
$100M
AUM
5.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Martlet Capital.
Investment Thesis & Strategy
Martlet Capital is an early-stage venture capital firm that invests in deep tech and life science startups with high growth potential. They provide patient capital to companies across various stages within the fintech sector.
Investment Activity
Deals per year over the last 9 years
1
20151
20161
20170
20184
20192
20201
20211
20221
2023Portfolio Companies
Selected investments from their portfolio of 36 companies
S
Symphony Therapeutics
Biotech · Series A, 2023
P
Purespring Therapeutics
Biotech · Series A, 2022
P
Peptone
Biotech · Series A, 2021
N
Nuclera
Biotech · Series A, 2020
B
Baseimmune
Biotech · Seed, 2020
C
Cambridge GaN Devices
Cleantech · Seed, 2019
Q
Qkine
Biotech · Seed, 2019
R
Riverlane
AI/ML · Series A, 2019
S
Sano Genetics
Biotech · Seed, 2019
B
Bit.bio
Biotech · Series A, 2017
M
Microbiotica
Biotech · Series A, 2016
C
Congenica
Biotech · Series A, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
GraphcoreAcquisition2024—
DeepMindAcquisition2014$500M
Frequently Asked Questions
Martlet Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Amadeus Capital Partners
Cambridge, United Kingdom · 224 deals
SyndicateRoom
Cambridge, United Kingdom · 89 deals
IQ Capital
Cambridge, United Kingdom · 81 deals
Cambridge Innovation Capital
Cambridge, United Kingdom · 58 deals
GEIF Ventures
Cambridge, United Kingdom · 19 deals
Acacia Capital Partners
Cambridge, United Kingdom · 9 deals